Patents Assigned to University of Texas System
  • Publication number: 20230406825
    Abstract: Compounds and methods are disclosed for the treatment and/or amelioration of breast cancer. The compounds and methods may treat and/or ameliorate breast cancer by way of activity on isocitrate dehydrogenase 1 (IDH1). The breast cancer may be estrogen receptor positive (ER+) breast cancer. Also disclosed are compositions, including pharmaceutical compositions, for the treatment and/or amelioration of breast cancer.
    Type: Application
    Filed: November 2, 2021
    Publication date: December 21, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Murat Can Cobanoglu, Ganesh Raj
  • Publication number: 20230405191
    Abstract: Antimicrobial catheters and medical devices are provided. In some aspects, a low durometer aliphatic polyether polyurethane may be impregnated with a first antimicrobial agent (e.g., minocycline and rifampin) and coated with a second antimicrobial agent (e.g., chlorhexidine, gendine, or gardine). The antimicrobial catheters may display improved flexibility and resistance to kinking. Methods of producing the antimicrobial catheters are also provided.
    Type: Application
    Filed: August 25, 2023
    Publication date: December 21, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: Joel ROSENBLATT, Issam RAAD
  • Publication number: 20230407223
    Abstract: A Micro-Well Array Plates (MWAP) assembly for high throughput microfluidic devices for studying cells and method of manufacturing thereof are provided. The MWAP assembly includes a top plate having a plurality of macro-wells arranged in an array within a frame. The MWAP assembly also includes a bottom plate operable to be secured to the bottom surface of the frame, the bottom plate having a plurality of arrays of micro-wells. The MWAP assembly includes a well grid formed when the bottom plate is secured to the top plate via the plurality of macro-wells and the plurality of arrays micro-wells. The well grid with the plurality of macro-wells and the plurality of arrays micro-wells enable visualization of cells via a high throughput.
    Type: Application
    Filed: October 22, 2021
    Publication date: December 21, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Robert M. BACHOO, Digant P. DAVÉ
  • Patent number: 11846382
    Abstract: A method for eliminating hydrocarbon fouling and reducing pumping power during hydrocarbon transportation. A dielectric layer covers the inner surface of a pipeline for transporting a water-hydrocarbon mixture. A proximity electrode is immersed in the water-hydrocarbon mixture, and an electrical voltage is applied across the dielectric layer. A buffer layer of water is formed on the dielectric layer since water is electrically attracted from the water-hydrocarbon mixture. This water layer, located between the dielectric layer and the water-hydrocarbon mixture, eliminates hydrocarbon fouling on the inner surface of the pipeline or any other internal surface that needs fouling protection. Alternatively, the dielectric layer covers an outer surface of the pipeline and is covered by an external conducting layer.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: December 19, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventor: Vaibhav Bahadur
  • Patent number: 11848073
    Abstract: A system for indexing, updating, and search haplotypes for genetic genealogical discovery in genotype databases. The system includes a pool of genetic indexes, a haplotype ingestion engine, and a haplotype query engine. The haplotypes of a number of individuals in a genotype database are indexed by a pool of multiple panels, and each panel pool can be dynamically updated by the insertion or deletion of individual haplotypes. A genetic genealogical search of a query haplotype against the database is achieved by first projecting the query onto a subset of panels in the pool, then conducting long match queries over each panel, and finally aggregating the identified long matches into Identical-by-Descent segments, i.e., DNA matches, between the query and the haplotypes in the database.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: December 19, 2023
    Assignees: University of Central Florida Research Foundation, Inc., The Board of Regents of the University of Texas System
    Inventors: Degui Zhi, Shaojie Zhang, Ardalan Naseri, Ahsan Sanaullah, Erwin Holzhauser
  • Publication number: 20230399277
    Abstract: Methods of using an organic framework (OF) are provided herein, including methods of using an OF comprising a repeat unit of the formula: The OFs provided herein may be used in the separation of two or more molecules from each other. In some embodiments, the molecules are propylene and propane.
    Type: Application
    Filed: May 16, 2023
    Publication date: December 14, 2023
    Applicants: Board of Regents, The University of Texas System, Fujian Normal University
    Inventors: Banglin CHEN, Zhangjing ZHANG, Shengchang XIANG
  • Publication number: 20230398539
    Abstract: A Cell Migration Assay Plates (CMAP) assembly for high throughput microfluidic migration assays and method of manufacturing thereof are provided. The CMAP assembly includes a top plate having a plurality of wells aligned with a bottom plate having a plurality of troughs. Each of the plurality of wells is defined at least in part by first and second reservoirs and a divisional wall extending between the reservoirs. The bottom plate is secured to the top plate to form a plurality of micro-channels, such that each one of the plurality of micro-channels is defined by a portion of one of the divisional walls and a portion of a corresponding one of the plurality of troughs. The plurality of micro-channels enable communication between the reservoirs and visualization of cells migrating through the micro-channels. In this manner, migration of cells through the micro-channels can be visualized for testing and screening applications.
    Type: Application
    Filed: October 22, 2021
    Publication date: December 14, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Robert M. BACHOO, Digant P. DAVÉ
  • Publication number: 20230398214
    Abstract: Methods of generating an isolated population of non-graft versus host disease (GVHD) inducing cells comprising a central memory T-lymphocyte (Tcm) phenotype, the cells being tolerance inducing cells and/or endowed with anti-disease activity, and capable of homing to the lymph nodes following transplantation, are disclosed. Cells generated by the methods, pharmaceutical compositions and methods of treatment are also disclosed.
    Type: Application
    Filed: August 6, 2020
    Publication date: December 14, 2023
    Applicants: Yeda Research and Development Co. Ltd., Board of Regents, The University of Texas System
    Inventors: Yair REISNER, Esther BACHAR-LUSTIG, Assaf LASK, Noga OR-GEVA, Rotem GIDRON BUDOVSKY, Rakefet SIDLIK MUSKATEL
  • Patent number: 11839615
    Abstract: The present invention relates to adenosine receptor agonist compounds and methods of use thereof for treatment of certain disorders and conditions, for example an addiction or compulsive disorder. Exemplary compounds for use in disclosed methods include: and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: December 12, 2023
    Assignees: Astrocyte Pharmaceuticals, Inc., The Board of Regents of the University of Texas System
    Inventors: William S. Korinek, Theodore E Liston, James D. Lechleiter, Michael Beckstead
  • Patent number: 11840690
    Abstract: Provided herein are compositions and methods for reducing expression of C9orf72 transcripts in cells containing expanded intronic GGGGCC regions, including those in subjects having or at risk of developing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: December 12, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: David Corey, Jiaxin Hu
  • Patent number: 11843339
    Abstract: A system and method estimate the fault severity index and consequently the number of shorted turns in permanent magnet motors (PMSM) with inter turn short circuit fault (ITSC). In this method, the machine is excited with DC current at stand still conditions to obtain the winding resistance seen by the d-axis of the machine. The estimated d-axis resistance contains useful information pertaining to the fault severity index, and is used to extract the fault severity index and the number of shorted turns in the faulty motor. The method enables the estimation of fault severity index without complex modeling with different machine prototypes, or FEA models to analyze the relationship between machine currents and short circuit current. To enhance the accuracy of the estimation method, this disclosure addresses issues associated with inverter non-linearity effects such as distortion voltage due to dead time effects and voltage drops across the switching devices.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: December 12, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Bilal Akin, Kudra Baruti, Vigneshwaran Gurusamy, Feyzullah Erturk
  • Patent number: 11840550
    Abstract: The present disclosure provides compounds that may be used as ligands in metal-catalyzed reactions, in particular 3,3?-bisilyl biaryl phosphoramidite compounds and processes for preparing the same.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: December 12, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Junha Jeon, Hiep Hoang Nguyen
  • Patent number: 11839650
    Abstract: The present application generally relates to the development of a universal influenza vaccine, or production of antibodies, capable of providing broad protection against various strains of the flu, using an informational spectrum method (ISM) to identify the common structural characteristics of influenza antigens.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: December 12, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Veljko Veljkovic, Slobodan Paessler
  • Publication number: 20230392125
    Abstract: Aspects of the present disclosure relate to methods for producing formative pluripotent stem cells (PSCs) by culturing cells in a medium that comprises a fibroblast growth factor (FGF) activator, a transforming growth factor beta (TGF-?) activator, and a WNT activator. Also provided are in vitro culture systems for producing the formative pluripotent stem cells.
    Type: Application
    Filed: October 19, 2021
    Publication date: December 7, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Jun WU, Leqian YU
  • Publication number: 20230390413
    Abstract: Endolysosomal targeting conjugates that are engineered to deliver cargo molecules such as cytotoxic drugs or imaging labels with improved efficiency to late endosomes and/or lysosomes in target cells such as tumor cells are described. The endolysosomal targeting conjugate includes a targeting component and a cargo component. The targeting component is configured to bind to a cell surface molecule of a target cell and the cargo component includes a cargo molecule. The targeting component and the cargo component may be fused by a covalent bond or associated by a non-covalent bond. The targeting component may bind to the cell surface molecule or the cargo component with higher affinity in the extracellular space than in an endolysosomal compartment of the target cell.
    Type: Application
    Filed: May 16, 2023
    Publication date: December 7, 2023
    Applicants: THE TEXAS A&M UNIVERSITY SYSTEM, Board of Regents of the University of Texas System
    Inventors: Elizabeth Sally WARD OBER, Raimund Johannes OBER, Jeffrey Che-Wei KANG, Wei SUN, Ran LI
  • Patent number: 11834640
    Abstract: Disclosed are devices for improving viability of isolated islets or ?-cells and stimulating insulin production from isolated islets or ?-cells and uses thereof for treating type 1 diabetes.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: December 5, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Michael Cho, Caleb Liebman
  • Patent number: 11834423
    Abstract: Small molecule inhibitors (SMIs) of the Prolactin receptor, pharmaceutical compositions of the SMIs, and methods for treating patients suffering from disorders characterized increased expression or excitation of the Prolactin receptor, including breast cancer, prostate cancer and nociceptive pain disorders such as migraine headache, by administering pharmaceutical compositions of SMIs are provided.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: December 5, 2023
    Assignees: University of Cincinnati, University of Texas System, The Hebrew University of Jerusalem
    Inventors: Nira Ben-Jonathan, Eric R. Hugo, Edward J. Merino, Abraham J. Domb, Armen N. Akopian
  • Publication number: 20230382982
    Abstract: Antibodies exhibiting a specific genetically modified signature associated with certain diseases of the central nervous system, like multiple sclerosis (MS) and clinically isolated syndrome have been identified. These antibodies recognize and bind with certain tissues in the brain and central nervous system and thus are useful as therapeutics, in the production of animal disease models, targets for therapies and as part of assays of the central nervous system.
    Type: Application
    Filed: November 28, 2022
    Publication date: November 30, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventor: Nancy MONSON
  • Publication number: 20230381293
    Abstract: Recombinant Norovirus Virus-Like Particles (VLPs) formed from recombinant Norovirus VP1 proteins, and methods of their use and production are disclosed. In several embodiments, the Recombinant Norovirus VLPs can be used to generate an immune response to Norovirus VP1 protein in a subject. In additional embodiments, an effective amount of the recombinant Norovirus VLPs can be administered to a subject in a method of inhibiting a Norovirus infection.
    Type: Application
    Filed: October 14, 2021
    Publication date: November 30, 2023
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Servic, The University of North Carolina at Chapel Hill, Board of Regents, the University of Texas System
    Inventors: Peter Kwong, Raffaello Verardi, Yaroslav Tsybovsky, Jason Gorman, Gwo-Yu Chuang, Li Ou, Lisa Lindesmith, Ralph Baric, George Georgiou, Inga Rimkute, Mario Roederer
  • Patent number: 11826332
    Abstract: In some aspects, provided herein are antimicrobial compositions comprising partially esterified polygalacturonic acid and certain fatty acids (e.g., caprylic acid). In some embodiments, the antimicrobial composition may be administered (e.g., topically or orally) to a subject, such as a human patient to treat an infection (e.g., an infection comprising a biofilm). In some aspects, improved catheters are provided.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: November 28, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Joel Rosenblatt, Issam Raad